Evolution Winning in Bacteria vs Antibiotics Arms Race

Science is running out of new ways to attack harmful bacteria, while drug companies are abandoning antibiotic research and development, according to a University of Adelaide drug expert.

Written byUniversity of Adelaide
| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00

Science is running out of new ways to attack harmful bacteria, while drug companies are abandoning antibiotic research and development, according to a University of Adelaide drug expert.

Speaking during Antibiotic Awareness Week (18-24 November), Dr. Ian Musgrave from the University's School of Medical Sciences says whenever a new antibiotic is developed, harmful bacteria evolve to become resistant within a relatively short period of time.

"There's no doubt that evolution is winning the antibiotics arms race," says Dr. Musgrave, a Senior Lecturer in Pharmacology.

To continue reading this article, sign up for FREE to
Lab Manager Logo
Membership is FREE and provides you with instant access to eNewsletters, digital publications, article archives, and more.

Related Topics

CURRENT ISSUE - October 2025

Turning Safety Principles Into Daily Practice

Move Beyond Policies to Build a Lab Culture Where Safety is Second Nature

Lab Manager October 2025 Cover Image